Exchange: NASDAQ·Updated 07:45 PM EDT
OABI logo

OABI OmniAb Inc

$4.44
$0.06
(1.37%)
Today
Closed $4.44
$0.059
(1.33%)
After Hours
Reported EarningsAug 6
Mkt Cap$636.81M
Vol1.16M

About OABI

OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
37

Bearish Sentiment

How do you feel about OABI?

Advertisement|Remove ads.